Grade/Stage I Hemorrhoids, Prolapsed Grade III Internal Haemorrhoid, Prolapsed Grade II Internal Haemorrhoid
Conditions
Keywords
hemorrhoids
Brief summary
Internal hemorrhoid affects the quality of life due to hemorrhage and prolapse as a common and frequently-occurring disease. Endoscopic sclerosing agent injection has replaced traditional surgery and become the most commonly used treatment method in developed countries. At present, how to reduce the side effects of sclerosing agent and accurately determine the injection site and depth has become a difficult clinical problem. The research group creatively put forward the theory of foam sclerosing agent to treat internal hemorrhoids in the early stage. With the aid of transparent cap, the visibility of surgical field of vision can be improved. The mini probe ultrasound (MPS) is proposed to effectively evaluate the submucosal in
Interventions
DRUGSclerosing foam of Lauromacrogol
Participants in FS will receive enteroscopy with the sclerosing foam of lauromacrogol.
DRUGSclersing liqiud of Lauromacrogol
Participants in LS will receive enteroscopy with the sclerosing liquid of lauromacrogol.
Sponsors
Tongren Hospital,Shanghai Jiao Tong University School of Medicine
Shanghai Construction Group Hospital
Shandong Maternal and Chidl Care Service Center
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
West China Fourth Hospital, Sichuan University
The First Hospital of Anhui Medical University
The First Affiliated Hospital of Zhengzhou University
Jiangsu Provincial Second Chinese Medicine Hospital
Anhui Provincial Hospital
Luoyang Central Hospital
Ganzhou Fifth pepole's Hospital
Changzhi People's Hospital
Nanjing PLA General Hospital
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* People are willing to sign the informed consent form of this trial. * People(aged 18 to 70 years) with clinical symptoms such as bleedingprolapse and so on have been diagnosed with grade I, grade II and grade III internal hemorrhoids by colonic epdoscopy; * People can follow short-term (3 month) and long-term (12 month) visit plans; * Describe symptoms objectively and actively complete the evaluation scale; * No allergic diseases and allergy to sclerosing drugs; * Non-lactating and pregnant women: patients without pregnancy plan (including the men) in 1 month after the test; * Did not participate in any drug trials (including this trial drug) within 3 months before the trial; * People with long-term use of anticoagulant drugs (such as aspirin, clopidogrel, etc.) need to be stopped for 5-7 day
Exclusion criteria
* People with severe insufficiency of heart, brain, lung and other organs, leading to inability to tolerate endoscopic treatment; * People with drug allergies or abnormal blood coagulation function; * People suffering from or combined with digestive tract diseases,such as the colon malignancyulcerative colitis or Crohn's diseaseacute diarrheaacute thrombotic internal hemorrhoids with painanal fistulaanal fissurefecal incontinence * Men with history of severe prostate hypertrop; * People with any reasons that the researchers believe can not be selected
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| the condition of bleeding、perianal pruritus 、the degree of prolapse of internal hemorrhoids and the influence of internal hemorrhoids by self-assessment. | 12 months | After 12 months,all the participants will receive the telephone follow-up to record their self-assessment. |
| the condition of perianal pruritus、the description of hemorrhoids(include the number and depth of hemorrhoids)、the need for additiongal sclerotherapy under colonic endoscopy. | 12 months | after 12 months ,all the participants will receive the colonic endoscopy and we will record the degree of prolapse of internal hemorrhoids、the numbers of hemorrhoid under colonic endoscopy. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| the condition of participants' bleeding、perianal pain and perianal pruritus after the endoscopic treatment. | 1 day | one day after receiving endoscopic treatment , all the participants will receive the telephone follow-up and we will record their self-assessment,include the condition of bleeding、perianal pain and perianal pruritus. |
| the condition of bleeding、perianal pruritus 、the degree of prolapse of internal hemorrhoids and the influence of internal hemorrhoids by self-assessment. | 3 months | After 3 months,all the participants will receive the telephone follow-up to record their self-assessment. |
| the condition of perianal pruritus、the description of hemorrhoids(include the number and depth of hemorrhoids)、the need for additiongal sclerotherapy under colonic endoscopy. | 3 months | after 3 months ,all the participants will receive the colonic endoscopy and we will record the degree of prolapse of internal hemorrhoids、the numbers of hemorrhoid under colonic endoscopy. |
Countries
China
Contacts
Primary ContactFeng Shen
Outcome results
None listed